Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Inflamm Bowel Dis. 2016 Sep;22(9):2149–2157. doi: 10.1097/MIB.0000000000000870

Table 1.

Demographic, disease, and admission characteristics of patients with IBD-related hospitalizations at MGH between July 2013 – April 2015

Characteristic Year 1 (General gastroenterology care) (n= 196) Year 2 (Specialized IBD care) (n= 212) p-value
Demographics
Mean age (SD) (in years) 41.4 (17.9) 39.6 (17.1) 0.30
Male 53 48 0.32
Smoking
 Never 58 59 0.45
 Current 12 16
 Former 30 25
Source of Admission
 Emergency department 74 63 0.004*
 Outpatient clinic 12 25
 Transfer from another hospital 14 12
Previous IBD-related
hospitalization 91 87 0.17
Previous IBD-related surgery 42 47 0.25
Age of Diagnosis (in years)
 ≤16 21 21 0.57
 17–40 55 60
 >40 24 20
Disease Characteristics
Type of IBD
 Crohn’s Disease 67 66 0.79
 Ulcerative Colitis 33 34
Disease Location (CD)
 Ileal 14 18 0.22
 Colonic 20 13
 Ileocolonic 66 69
Upper GI involvement (CD) 12 10 0.63
Disease Behavior (CD)
 Inflammatory 22 17 0.57
 Stricturing 23 25
 Penetrating 55 58
Perianal involvement (CD) 36 45 0.15
Disease Extent (UC)
 Left-sided colitis 38 25 0.05*
 Pancolitis 63 75
Past Medications (%)
 5-ASA 67 62 0.37
 Immunomodulators 57 59 0.70
 Biologics 54 54 0.88
Characteristics at Hospitalization
Current Medications
 Immunomodulators 19 27 0.09
 Biologics 30 39 0.04*
 Steroids 45 45 0.94
Admission Labs (Mean(SD))
 Hemoglobin (g/dL) 11.6 (2.5) 11.8 (2.3) 0.36
 Albumin (g/dL) 3.6 (0.7) 3.7 (0.6) 0.21
 Erythrocyte sedimentation rate (mm/hr) 38.7 (32.9) 39.3 (28.1) 0.86
 C-reactive protein (mg/L) 53.8 (58.6) 62.1 (61.5) 0.22

All figures represent percentages unless indicated otherwise

SD – standard deviation; IBD – inflammatory bowel disease; CD – Crohn’s disease; UC – ulcerative colitis; 5-ASA – 5-aminosalicylic acid; g/dL – gram/deciliter; mm/hr – millimeter/hour; mg/L – milligram/liter

*

p ≤ 0.05